Reflections on TORCH: potential mechanisms for the survival benefit of salmeterol/fluticasone propionate in COPD patients.
about
Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysisCombined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary diseaseCombined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
P2860
Reflections on TORCH: potential mechanisms for the survival benefit of salmeterol/fluticasone propionate in COPD patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Reflections on TORCH: potentia ...... e propionate in COPD patients.
@en
Reflections on TORCH: potentia ...... e propionate in COPD patients.
@nl
type
label
Reflections on TORCH: potentia ...... e propionate in COPD patients.
@en
Reflections on TORCH: potentia ...... e propionate in COPD patients.
@nl
prefLabel
Reflections on TORCH: potentia ...... e propionate in COPD patients.
@en
Reflections on TORCH: potentia ...... e propionate in COPD patients.
@nl
P2093
P2860
P1476
Reflections on TORCH: potentia ...... e propionate in COPD patients.
@en
P2093
A G N Agusti
N C Barnes
P2860
P304
P356
10.1080/15412550802522924
P407
P577
2008-12-01T00:00:00Z